Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Statistics

Total Valuation

CLDX has a market cap or net worth of $1.21 billion. The enterprise value is $493.36 million.

Market Cap	1.21B
Enterprise Value	493.36M

Important Dates

The next estimated earnings date is Monday, May 5, 2025, after market close.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

CLDX has 66.38 million shares outstanding. The number of shares has increased by 32.91% in one year.

Current Share Class	66.38M
Shares Outstanding	66.38M
Shares Change (YoY)	+32.91%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	0.28%
Owned by Institutions (%)	103.98%
Float	57.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	167.87
Forward PS	344.08
PB Ratio	1.63
P/TBV Ratio	1.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	70.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.91, with a Debt / Equity ratio of 0.01.

Current Ratio	18.91
Quick Ratio	18.38
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.84% and return on invested capital (ROIC) is -20.62%.

Return on Equity (ROE)	-26.84%
Return on Assets (ROA)	-19.38%
Return on Invested Capital (ROIC)	-20.62%
Return on Capital Employed (ROCE)	-25.91%
Revenue Per Employee	$37,742
Profits Per Employee	-$848,726
Employee Count	186
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.62% in the last 52 weeks. The beta is 1.59, so CLDX's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	-52.62%
50-Day Moving Average	19.87
200-Day Moving Average	28.49
Relative Strength Index (RSI)	49.59
Average Volume (20 Days)	935,834

Short Selling Information

The latest short interest is 8.30 million, so 12.51% of the outstanding shares have been sold short.

Short Interest	8.30M
Short Previous Month	9.15M
Short % of Shares Out	12.51%
Short % of Float	14.37%
Short Ratio (days to cover)	10.20

Income Statement

In the last 12 months, CLDX had revenue of $7.02 million and -$157.86 million in losses. Loss per share was -$2.45.

Revenue	7.02M
Gross Profit	-156.53M
Operating Income	-195.08M
Pretax Income	-150.22M
Net Income	-157.86M
EBITDA	-191.90M
EBIT	-195.08M
Loss Per Share	-$2.45

Balance Sheet

The company has $725.28 million in cash and $3.81 million in debt, giving a net cash position of $721.47 million or $10.87 per share.

Cash & Cash Equivalents	725.28M
Total Debt	3.81M
Net Cash	721.47M
Net Cash Per Share	$10.87
Equity (Book Value)	747.01M
Book Value Per Share	11.25
Working Capital	707.66M

Cash Flow

In the last 12 months, operating cash flow was -$157.78 million and capital expenditures -$1.92 million, giving a free cash flow of -$159.70 million.

Operating Cash Flow	-157.78M
Capital Expenditures	-1.92M
Free Cash Flow	-159.70M
FCF Per Share	-$2.41

Margins

Gross Margin	n/a
Operating Margin	-2,778.89%
Pretax Margin	-2,248.76%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.91%
Shareholder Yield	n/a
Earnings Yield	-12.99%
FCF Yield	-13.15%

Analyst Forecast

The average price target for CLDX is $54.29, which is 196.83% higher than the current price. The consensus rating is "Buy".

Price Target	$54.29
Price Target Difference	196.83%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	155.13%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on February 11, 2019. It was a reverse split with a ratio of 0.0666666:1.

Last Split Date	Feb 11, 2019
Split Type	Reverse
Split Ratio	0.0666666:1

Scores

CLDX has an Altman Z-Score of 27.88 and a Piotroski F-Score of 2.

Altman Z-Score	27.88
Piotroski F-Score	2